Fujian Cosunter Pharmaceutical's controlling shareholder is planning to transfer 5.02% of its shares to Yuanshan Fund through an agreement.
Guangshengtang (300436.SZ) announcement, the company's controlling shareholder Fujian Aohua Group Co., Ltd. and Zhangzhou Yuanshan Health...
Fujian Cosunter Pharmaceutical (300436.SZ) announced that the company's controlling shareholder, Fujian Aohua Group Co., Ltd., has signed a "Share Transfer Agreement" with Zhangzhou Yuanshan Health Industry Investment Fund Partnership Enterprise (Limited Partnership). The company plans to transfer a total of 8 million shares of the company's unrestricted tradable shares, accounting for 5.02% of the total share capital, to Yuanshan Fund through the agreement. The transfer price for this share transfer agreement is 24.5 yuan per share, with a total transfer price of 196 million yuan. Both parties will jointly promote the industrial cooperation and development between Fujian Cosunter Pharmaceutical and Zhangzhou Health Industry Chain, enhancing industrial synergy and complementary advantages.
Related Articles

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


